Symrise (SY1) AI Stock Analysis

• Market Cap: €14.66B
• Dividend Yield: 1.14%
• Average Volume (3M): 310.11K
• Price to Earnings (P/E): 30.6
• Beta (1Y): 0.48
• Revenue Growth: 5.67%
• EPS Growth: 40.46%
• Country: DE
• Employees: 12,385
• Sector: Consumer Defensive
• Sector Strength: 68
• Industry: Chemicals - Specialty
• EPS (TTM): 1.71
• Shares Outstanding: 139,772,050
• 10 Day Avg. Volume: 283,010
• 30 Day Avg. Volume: 310,108
• PEG Ratio: 2.73
• Price to Book (P/B): 3.39
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 54.32
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €115.82
• Price Target Upside: 10.46% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 13

• Rating: 75 Outperform
• Price Target: €120.00 ▲(14.45%Upside)

Symrise's stock score reflects strong financial performance and bullish technical indicators, which are offset by a high valuation suggesting limited upside potential. The company's robust revenue and profitability growth, efficient cost management, and operational improvements are key strengths. However, the high P/E ratio indicates the stock is priced for growth, which may limit further price appreciation unless earnings growth continues. Technical analysis supports the current bullish trend, but caution is advised due to overbought signals.

Positive Factors

Growth Strategy

Symrise announced a public offer to acquire outstanding Probi shares, aiming to increase efficiency and promote top-line synergies between the two companies.

Guidance

Symrise has slightly upgraded its FY 2024 guidance, expecting organic sales growth of more than 7% and an EBITDA margin above 20%.

Profitability

Symrise is committed to +200bps EBITDA margin expansion by 2028.

Negative Factors

Market Performance

Relative performance against the DAX shows a decline of 6.3% year to date and 14.4% over the trailing 12 months.

Sales Growth

Q1-25 organic sales growth should be slow, mainly due to a tough comparable.

Symrise Business Overview & Revenue Model

Company Description

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, aroma molecules, cosmetic ingredients, and mint flavors, as well as specific application processes for such substances. This segment's products are used by manufacturers of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. It operates in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. Symrise AG was founded in 1874 and is headquartered in Holzminden, Germany.

How the Company Makes Money

Symrise generates revenue primarily through the development, production, and sale of fragrances and flavors, which are used in a wide range of consumer goods, including food, beverages, personal care, and household products. The company's key revenue streams are divided between its two main segments: Flavor & Nutrition, which includes flavorings and functional ingredients for the food and beverage industry, and Scent & Care, which comprises fragrances and cosmetic ingredients. Symrise's earnings are bolstered by strategic partnerships and collaborations with leading consumer goods companies, as well as its focus on sustainable and innovative product offerings that meet evolving consumer preferences. This approach helps the company maintain a competitive edge and drive growth in its core markets.

Symrise Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
3.66B	4.73B	4.62B	3.83B	3.52B	3.41B
	Gross Profit
1.39B	1.69B	1.70B	1.48B	1.39B	1.37B
	EBIT
120.02M	559.36M	503.98M	558.96M	487.51M	464.19M
	EBITDA
700.03M	841.49M	769.91M	806.40M	742.02M	702.81M
	Net Income Common Stockholders
315.57M	340.47M	280.01M	374.92M	306.87M	298.31M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
287.43M	393.03M	314.86M	465.14M	740.31M	457.82M
	Total Assets
4.92B	7.85B	7.78B	6.64B	5.94B	5.96B
	Total Debt
1.66B	2.56B	2.55B	1.80B	2.07B	2.06B
	Net Debt
1.38B	2.17B	2.23B	1.35B	1.35B	1.62B
	Total Liabilities
2.98B	4.16B	4.17B	3.39B	3.58B	3.49B
	Stockholders Equity
1.89B	3.63B	3.55B	3.19B	2.30B	2.41B
Cash Flow		Free Cash Flow
368.87M	449.31M	109.94M	347.40M	491.64M	372.36M
	Operating Cash Flow
555.59M	719.51M	360.11M	521.56M	635.68M	546.77M
	Investing Cash Flow
-275.92M	-358.29M	-984.84M	-713.60M	-149.71M	-881.89M
	Financing Cash Flow
-339.91M	-264.22M	481.52M	-92.15M	-188.75M	497.73M

Symrise Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 104.85
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:SY1, the sentiment is Positive. The current price of 104.85 is above the 20-day moving average (MA) of 103.57, above the 50-day MA of 98.74, and above the 200-day MA of 103.74, indicating a bullish trend. The MACD of 1.84 indicates Positive momentum. The RSI at 58.99 is Neutral, neither overbought nor oversold. The STOCH value of 62.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:SY1.

Symrise Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SY1	75 Outperform	€14.66B	30.64	12.56%	1.14%	5.67%	40.46%
Sector *	65 Neutral	$8.88B	14.98	4.76%	203.76%	3.54%	-2.49%
0MPT		€8.74B	16.57	11.49%	3.46%	―	―
0RBE		€11.05B	―	-6.00%	―	―	―
0QDS		€8.88B	29.86	3.25%	6.11%	―	―
FPE	76 Outperform	€5.52B	15.74	15.87%	3.20%	2.58%	8.02%
WKCMF		$3.56B	13.43	5.37%	3.84%	―	―